The DOI matches its Crossref record; 233 of the 233 references it cites were found in a registry or an index.
Role of advanced glycation end products in cellular signaling
Open accessAbstract
Improvements in health care and lifestyle have led to an elevated lifespan and increased focus on age-associated diseases, such as neurodegeneration, cardiovascular disease, frailty and arteriosclerosis. In all these chronic diseases protein, lipid or nucleic acid modifications are involved, including cross-linked and non-degradable aggregates, such as advanced glycation end products (AGEs). Formation of endogenous or uptake of dietary AGEs can lead to further protein modifications and activation of several inflammatory signaling pathways. This review will give an overview of the most prominent AGE-mediated signaling cascades, AGE receptor interactions, prevention of AGE formation and the impact of AGEs during pathophysiological processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These AGE cell surface receptors include AGE-R1, AGE-R2, AGE-R3, and scavenger receptors such as macrophage scavenger receptors, scavenger receptor class B type I and II (SR-BI, SR-BII), and cluster of differentiation 36 (CD36).”
From Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury (2021) · cites this paper as [46]
In the citing paper
“The interaction of AGEs with these receptors can enhance their catabolism and clearance by modulating endocytosis and degradation45,46, suggesting a potentially adaptive defensive mechanism in the body to reduce the detrimental effects of increased glycation products.”
From Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury (2021) · cites this paper as [46]
In the citing paper
“Notably, several conditions, including aging, diabetes, renal failure, tobacco smoking, and excessive alcohol consumption that induce AGE accumulation and AGE-RAGE interaction, are risk factors for increased bone fracture and osteoporosis46,85.”
From Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury (2021) · cites this paper as [46]
In the citing paper
“In addition to lipid peroxide-related protein adducts, recent data suggest that sugar moiety-related protein adduct such as advanced glycation end products (AGEs) can be produced by high fat or excessive alcohol exposure or under pathological states such as diabetes, cardiovascular diseases and Alzheimer's disease, as recently reviewed [190], [191], [192], [193].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–233 of 233
Aβ-AGE aggravates cognitive deficit in rats via RAGE pathway
Chen, C., Li, X.-H., Tu, Y., Sun, H.-T., Liang, H., Cheng, S., & Zhang, S. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.10.056 · Cited by 46
Yagame, M., Kim, Y., Zhu, D., Suzuki, D., Eguchi, K., Nomoto, Y., Sakai, H., Groppoli, T. J., Steffes, M. W., & Mauer, M. S. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000188542 · Cited by 46
Identification of 80K-H as a protein involved in GLUT4 vesicle trafficking
Hodgkinson, C. P., Mander, A., & Sale, G. J. (2005) · Biochemical Journal · doi:10.1042/bj20041845 · Cited by 45
The receptor for advanced glycation end-products supports lung tissue biomechanics
Al‐Robaiy, S., Weber, B., Simm, A., Diez, C., Rolewska, P., Silber, R., & Bartling, B. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00090.2013 · Cited by 45
Pollreisz, A., Hudson, B. I., Chang, J. S., Qu, W., Cheng, B., Papapanou, P. N., Schmidt, A. M., & Lalla, E. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.07.011 · Cited by 45
Pathological Roles of Advanced Glycation End Product Receptors SR‐A and CD36
Horiuchi, S., Unno, Y., Usui, H. K., Shikata, K., Takaki, K., Koito, W., SAKAMOTO, Y., Nagai, R., MAKINO, K., SASAO, A., et al. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.076 · Cited by 41
Fineschi, S., Cunto, G. D., Facchinetti, F., Civelli, M., Imbimbo, B. P., Carnini, C., Villetti, G., Lunghi, B., Stochino, S., Gibbons, D. L., et al. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0111oc · Cited by 41
Liu, Y., Qu, Y., Wang, R., Ma, Y., Xia, C., Gao, C., Liu, J., Lian, K., Aibing, X., Lu, X., et al. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00075.2012 · Cited by 40
Nagai, R., Mera, K., Nakajou, K., Fujiwara, Y., Iwao, Y., Imai, H., Murata, T., & Otagiri, M. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.09.001 · Cited by 39
Subramanian, U., Gopi, V., & Vellaichamy, E. (2013) · Cardiovascular Toxicology · doi:10.1007/s12012-013-9222-2 · Cited by 38
Sevillano, N., Girón, M. D., Salido, M., Vargas, A. M., Vilches, J., & Salto, R. (2008) · The Journal of Biochemistry · doi:10.1093/jb/mvn137 · Cited by 37
Shiu, S. W. M., Wong, Y., & Tan, K. C. B. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11742 · Cited by 33
Falcone, C., Bozzinì, S., D’Angelo, A., Matrone, B., Colonna, A., Benzi, A., Paganini, E. M., Falcone, R., & Pelissero, G. (2013) · Disease Markers · doi:10.1155/2013/129360 · Cited by 32
Advanced glycation end products enhance monocyte activation during human mixed lymphocyte reaction
Ohashi, K., Takahashi, H. K., Mori, S., Liu, K., Wake, H., Sadamori, H., Matsuda, H., Yagi, T., Yoshino, T., Nishibori, M., et al. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.10.008 · Cited by 27
Nakano, N., Takaki, K., Jono, T., Nakajou, K., Eto, N., Horiuchi, S., Takeya, M., & Nagai, R. (2006) · The Journal of Biochemistry · doi:10.1093/jb/mvj092 · Cited by 27
Accumulation of Maillard Reaction Products in Skin Collagen in Diabetes and Aginga
Dyer, D. G., Dunn, J. A., Thorpe, S. R., Lyons, T. J., McCance, D. R., & Baynes, J. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb38687.x · Cited by 27
Zq, G., Yang, C., Yy, W., Wang, P., Chen, H., Xd, Z., Liu, R., Li, W., Xj, Q., Liang, X., et al. (2008) · PubMed · Cited by 27
Adachi, H., & Tsujimoto, M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.02.011 · Cited by 26
RAGE supports parathyroid hormone-induced gains in femoral trabecular bone
Philip, B. K., Childress, P., Robling, A. G., Heller, A., Nawroth, P. P., Bierhaus, A., & Bidwell, J. P. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00564.2009 · Cited by 26
Endocytosis of Advanced Glycation End-Products in Bovine Choriocapillaris Endothelial Cells
Li, R., McCourt, P., Schledzewski, K., Goerdt, S., Moldenhauer, G., Liu, X., Smedsrød, B. H., & Sørensen, K. K. (2009) · Microcirculation · doi:10.1080/10739680903133185 · Cited by 25
Yamagishi, S., Matsui, T., & Nakamura, K. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.03.020 · Cited by 24
Kamioka, M., Ishibashi, T., Ohkawara, H., Nagai, R., Sugimoto, K., Uekita, H., Matsui, T., Yamagishi, S., Ando, K., Sakamoto, T., et al. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22492 · Cited by 23
Ko, S., Lin, I.-H., Shieh, T., Ko, H., Chen, H., Chi, T.-C., Chang, S.-S., & Hsu, Y. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-012-9501-8 · Cited by 22
Biocca, S., Arcangeli, T., Tagliaferri, E., Testa, B., Vindigni, G., Oteri, F., Giorgi, A., Iacovelli, F., Novelli, G., Desideri, A., et al. (2013) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.10.001 · Cited by 21
Lung level of HMBG1 is elevated in response to advanced glycation end product‐enriched food in vivo
Bartling, B., Fuchs, C., Somoza, V., Niemann, B., Silber, R., & Simm, A. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200600223 · Cited by 21
Brûlé, S., Rabahi, F., Faure, R. L., Beckers, J., Silversides, D. W., & Lussier, J. G. (2000) · Biology of Reproduction · doi:10.1095/biolreprod62.3.642 · Cited by 21
Der bemerkenswerte Anstieg der Lebenserwartung und sein Einfluss auf die Medizin
Vaupel, J. W., & von Kistowski, K. G. (2005) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-005-1043-4 · Cited by 18
Kim, S.-J., Ahn, J., Kim, H. Y., Ha, H.-J., Lee, S., Kim, H. K., Lee, S., Hong, H., Kim, Y. H., & Choi, C. Y. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.08.047 · Cited by 17
Brisslert, M., Amu, S., & Pullerits, R. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1508-3 · Cited by 15
The effect of an AGE-rich dietary extract on the activation of NF-κB depends on the cell model used
Pötzsch, S., Blankenhorn, A., Santos, A. N., Silber, R.-E., Somoza, V., & Simm, A. (2013) · Food & Function · doi:10.1039/c3fo30349g · Cited by 14
Mizutani, K., Ikeda, K., Ito, T., Tamaki, K., Nara, Y., & Yamori, Y. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018080-00012 · Cited by 14
Li, S., Guo, Y., Zhu, P., & Ting-shu, Y. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.09.005 · Cited by 13
Diabetes mellitus and coronary heart disease ‐ from prevention to intervention: Part I
Farouque, H. M. O., O’Brien, R. C., & Meredith, I. T. (2000) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.2000.tb00837.x · Cited by 12
Flagged first, then by citations
Cited by
Sorted by citations
Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus
Nowotny, K., Jung, T., Höhn, A., Weber, D., & Grune, T. (2015) · Biomolecules · doi:10.3390/biom5010194 · Cited by 1,095
Self-citationKang, Q., & Yang, C. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101799 · Cited by 1,134
Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives
Khalid, M., Petroianu, G. A., & Adem, A. (2022) · Biomolecules · doi:10.3390/biom12040542 · Cited by 972
Redox regulation of FoxO transcription factors
Klotz, L.-O., Sánchez-Ramos, C., Prieto-Arroyo, I., Urbánek, P., Steinbrenner, H., & Monsalve, M. (2015) · Redox Biology · doi:10.1016/j.redox.2015.06.019 · Cited by 747
Twarda‐Clapa, A., Olczak, A., Białkowska, A. M., & Koziołkiewicz, M. (2022) · Cells · doi:10.3390/cells11081312 · Cited by 829
Metadata
- Authors
- Ott, C., Jacobs, K., Haucke, E., Navarrete Santos, A., Grune, T., & Simm, A.
- Affiliations
- Friedrich Schiller University Jena (DE)
- University Hospital in Halle (DE)
- Martin Luther University Halle-Wittenberg (DE)
- Corresponding author
- Simm, Andreas
- Venue
- Redox Biology
- Publisher
- Elsevier BV
- Published
- 2014
- Volume
- 2
- Pages
- 411-429
- ISSN
- 2213-2317 (ISSN-L)
- PMC
- PMC3949097
- OpenAlex
- W2086327676
- Cited by
- 1,150
- References
- 233
- Citations by year
- 2026: 62 · 2025: 82 · 2024: 105 · 2023: 121 · 2022: 108 · 2021: 131 · 2020: 107 · 2019: 106 · 2018: 86 · 2017: 94 · 2016: 70 · 2015: 52 · 2014: 21
- FWCI
- 10.15
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Redox Biology (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Agricultural and Biological Sciences › Food Science › Potato Plant Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- advanced glycation end products, AGE receptor, signal transduction, protein modification, inflammatory signaling, age-related diseases, neurodegeneration, cardiovascular disease, arteriosclerosis, frailty, dietary AGEs
- MeSH terms
- Receptor for Advanced Glycation End Products, Aging, Animals, Bone and Bones, Dietary Proteins, Humans, Hyperglycemia, Immune System, Inflammation, Lung, Models, Biological, Neurons, Polymers, Receptors, Immunologic, Lipid Peroxidation, Signal Transduction, Maillard Reaction, NF-kappa B, Glycation End Products, Advanced, Reactive Oxygen Species, Oxidative Stress, Protein Transport, Reactive Nitrogen Species, Receptors, Scavenger, Protein Aggregates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
